Clinical Case of Urothelial Carcinoma with Implantation Metastasis
https://doi.org/10.24835/1607-0763-2017-6-88-99
Abstract
Urothelial cancer ranks 4th in the prevalence of malignant tumors after prostate cancer (or mammary glands), lung and colorectal cancer. Urothelial cancer of the upper urinary tract is quite rare and accounts for 5–10% of all cases of urothelial cancer. The leading clinical symptom of cancer of the renal pelvis and ureter is hematuria. Metastasis of tumors of the upper urinary tract is observed quite often. Metastasis of the tumor can be carried out lymphogenically into the para-aortic and parailiac lymph nodes, hematogenous to the liver, lungs, and bones. In addition, urothelial cancer often spreads through the urinary tract mucosa, mainly in the caudal direction. Currently, multidetector computer urography is considered the gold standard for examining the upper urinary tract, taking the place of excretory urography. This study should be performed under optimal conditions, especially with the inclusion of the excretory phase. It is necessary to perform scanning in a spiral mode (with a step of 1 millimeter) before and after the contrast medium. Clinical case of a patient with urethral carcinoma with implantation metastases in the ureter and in the bladder is presented.
About the Authors
Yu. A. Stepanova
A.V. Vishnevsky Institute of Surgery
Russian Federation
Russian Federation
Yulia A. Stepanova – doct. of med. sci., the senior research of radiology methods of diagnostics and treatment department.
117997, Moscow, Bol. Serpukhovskaya str., 27, Phone: +7-499-236-44-14
M. V. Morozova
A.V. Vishnevsky Institute of Surgery
Russian Federation
Russian Federation
Mariya V. Morozova – graduate student of ultrasound diagnostics department.
Moscow
A. A. Teplov
A.V. Vishnevsky Institute of Surgery
Russian Federation
Russian Federation
Aleksandr A. Teplov – doct. of med. sci., professor, Deputy Director.
MoscowA. A. Gritskevich
A.V. Vishnevsky Institute of Surgery
Russian Federation
Russian Federation
Aleksandr A. Gritskevich – cand. of med. sci., the senior research of the Urology department.
MoscowS. S. Pyanikin
A.V. Vishnevsky Institute of Surgery
Russian Federation
Russian Federation
Sergey S. Pyanikin – junior researcher of the Urology department.
MoscowA. E. Zotikov
A.V. Vishnevsky Institute of Surgery
Russian Federation
Russian Federation
Andrey E. Zotikov – doct. of med. sci., professor, leading research of the of the vascular surgery department.
MoscowS. А. Dunaev
Chechen State University
Russian Federation
Russian Federation
Saikhan A. Dunaev – assistant of the Faculty Surgery Department.
GroznyN. I. Yashina
A.V. Vishnevsky Institute of Surgery
Russian Federation
Russian Federation
Nina I. Yashina – doct. of med. sci., the senior research of radiology department.
MoscowN. K. Ratnikova
A.V. Vishnevsky Institute of Surgery
Russian Federation
Russian Federation
Natalia K. Ratnikova – pathologist of Pathology Department.
Moscow
References
1. Figurin K.M. Malignant neoplasms of renal pelvis and ureter. Oncourologiya. 2006; 2: 5–12. (In Russian)
2. Clinical recommendations for the diagnosis and treatment of patients with tumors of the upper urinary tract. Project. Volkova M.I., Matveev V.B., Medvedev S.V. et al. M., 2014. 15 p. (In Russian)
3. Mebel M. Tumors of the renal pelvis and ureter. In: Clinical urology. Ed. E.B. Marinbach. M., 1975. P. 57–66. (In Russian)
4. Rouprêt M., Babjuk M., Compérat E., Zigeuner R., Sylvester R.J., Burger M., Cowan N.C., Böhle A., Van Rhijn B.W., Kaasinen E., Palou J ,.Shariat S.F.. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update. Eur. Urol. 2015; 68 (5): 868–879. DOI: 10.1016/j.eururo.2015.06.044.
5. Urology. Clinical recommendations. 3rd ed., revised. Moscow: GEOTAR-Media, 2014. 650 p. (In Russian)
6. Akopyan G.N., Alyaev Yu.G., Gazimiev MA, Dymov AM, Chernov Ya.N. Percutaneous removal of urothelial cancers of the upper urinary tract. Meditsinskiy vestnik Bashkortostana. 2017; 12, 3 (69): 66–70. (In Russian)oscow.
7. Catalona W.J. Urothelial tumors of the urinary tract. In: Campbell‘s urology. 6-th ed. Ed. P.C. Walsh. 1992: 1094–1158.
8. Hisataki T., Miyao N., Masumori N., Takahashi A., Sasai M., Yanase M., Itoh N., Tsukamoto T. Risk factors for development of bladder cancer after upper tract urothelial cancer. Urology. 2000; 55: 663–667.
9. Afonin S.V. Modern diagnostics and treatment of urothelial cancers of the upper urinary tract. Author's abstract: Diss ... cand. med. sci. M., 2011. 26 p. (In Russian)
10. Lughezzani G., Sun M., Perrotte P., Shariat S.F., Jeldres C., Budäus L., Latour M., Widmer H., Duclos A.,.Bénard F., McCormack M., Montorsi F., Karakiewicz P.I. Genderrelated differences in patients with stage I to III upper tract urothelial carcinoma: results from the Surveillance, Epidemiology, and End Results database. Urology. 2010; 75 (2): 21–27. DOI: 10.1016/j.urology.2009.09.048.
11. Ishchenko K.B. Epidemiology, clinic and diagnosis of urothelial tumors of the renal pelvis and ureter: current state of the problem. Zlokachestvennie opukholi. 2016; 2 (18): 66–71. (In Russian)
12. Laing C., Hamour S., Sheaff M., Miller R., Woolfson R. Chinese herbal uropathy and nephropathy. Lancet. 2006; 368 (9532): 338.
13. Andreeva Yu.Yu., Zavalishina L.E., Morozov A.A. Detection of human papillomavirus DNA in superficial urothelial bladder carcinoma. Oncouroloigya. 2008; 1: 34–35. (In Russian)
14. Xylinas E., Rink M., Margulis V., Karakiewicz P., Novara G., Shariat S.F. Multifocal carcinoma in situ of the upper tract is associated with high risk of bladder cancer recurrence. Eur. Urol. 2012; 61: 1069–1070. DOI: 10.1016/j.eururo.2012.02.042.
Review
For citations:
Stepanova Yu.A., Morozova M.V., Teplov A.A., Gritskevich A.A., Pyanikin S.S., Zotikov A.E., Dunaev S.А., Yashina N.I., Ratnikova N.K. Clinical Case of Urothelial Carcinoma with Implantation Metastasis. Medical Visualization. 2017;(6):88-99. (In Russ.) https://doi.org/10.24835/1607-0763-2017-6-88-99
Views:
1485
Email this article 